Back to Search
Start Over
Simultaneous EGFR mutation detection and copy number assessment in circulating tumour DNA (ctDNA) to inform molecular methods of therapy resistance and plasma ctDNA content in lung adenocarcinoma
- Source :
- Journal of Clinical Oncology. 34:e23027-e23027
- Publication Year :
- 2016
- Publisher :
- American Society of Clinical Oncology (ASCO), 2016.
-
Abstract
- e23027Background: EGFR circulating tumour DNA (ctDNA) is a dynamic blood-borne marker predictive of EGFR tyrosine kinase inhibitor treatment response and disease progression. Microdroplet digital P...
- Subjects :
- Cancer Research
Treatment response
Lung
business.industry
Disease progression
02 engineering and technology
010402 general chemistry
021001 nanoscience & nanotechnology
medicine.disease
01 natural sciences
0104 chemical sciences
chemistry.chemical_compound
medicine.anatomical_structure
Oncology
chemistry
Egfr mutation
medicine
Cancer research
Adenocarcinoma
Treatment resistance
0210 nano-technology
business
Egfr tyrosine kinase
DNA
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 34
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........4bb08f5d7409a691b66ce371b94e3b8e
- Full Text :
- https://doi.org/10.1200/jco.2016.34.15_suppl.e23027